Quest Diagnostics Incorporated
DGX
Rang in aandelen
#929
Quest Diagnostics Incorporated, founded in 1967 and headquartered in Secaucus,... Quest Diagnostics Incorporated, founded in 1967 and headquartered in Secaucus, New Jersey, is a premier provider of diagnostic testing, information, and related services, serving clients both domestically and internationally. Its core business involves the development and provision of diverse diagnostic information services, such as routine, advanced clinical, and anatomic pathology testing. While primarily operating under the Quest Diagnostics brand, it also leverages specialized identities like AmeriPath, Dermpath Diagnostics, ExamOne, and Quanum to reach a broad spectrum of clients. Its extensive client base includes patients, clinicians, hospitals, integrated delivery networks, health plans, employers, and other direct healthcare entities. Delivery of these services is facilitated through a robust network comprising laboratories, patient service centers, in-office phlebotomists, call centers, and mobile health professionals including paramedics and nurses. Additionally, the company provides risk assessment services for the life insurance industry and offers comprehensive information technology solutions to healthcare organizations and clinicians.
Aandeelprijs
$236.69
Laatst gesynchroniseerd: 2026-10-20
Marktkapitalisatie
$26.12B
Verandering (1 dag)
0.80%
Verandering (1 jaar)
28.19%
Land
US
Handel Quest Diagnostics Incorporated (DGX)
Categorie
Healthcare
P/B-ratio voor Quest Diagnostics Incorporated (DGX)
P/B-ratio op October 2026 TTM: 3.42
Volgens de meest recente financiële rapporten en aandelenkoers van Quest Diagnostics Incorporated is de huidige P/B-ratio (TTM) 3.42. Eind 2024 had het bedrijf een P/B-ratio van 2.47.
P/B-ratiohistoriek voor Quest Diagnostics Incorporated van 2000 tot 2026
P/B-ratio aan het einde van elk jaar
| Jaar | P/B-ratio | Wijzigen |
|---|---|---|
| 2026 (TTM) | 3.42 | 27.00% |
| 2025 | 2.69 | 8.73% |
| 2024 | 2.47 | 0.90% |
| 2023 | 2.45 | -20.49% |
| 2022 | 3.08 | -8.24% |
| 2021 | 3.36 | 42.05% |
| 2020 | 2.36 | -6.87% |
| 2019 | 2.54 | 16.84% |
| 2018 | 2.17 | -20.81% |
| 2017 | 2.74 | -1.37% |
| 2016 | 2.78 | 27.11% |
| 2015 | 2.19 | -3.26% |
| 2014 | 2.26 | 9.68% |
| 2013 | 2.06 | -7.14% |
| 2012 | 2.22 | -11.03% |
| 2011 | 2.50 | 6.13% |
| 2010 | 2.35 | -16.44% |
| 2009 | 2.81 | 0.56% |
| 2008 | 2.80 | -9.01% |
| 2007 | 3.08 | -11.07% |
| 2006 | 3.46 | -8.05% |
| 2005 | 3.76 | -11.59% |
| 2004 | 4.25 | 34.62% |
| 2003 | 3.16 | 1.84% |
| 2002 | 3.10 | -38.04% |
| 2001 | 5.01 | -18.71% |
| 2000 | 6.16 | 0.00% |
P/B-ratio voor vergelijkbare bedrijven of concurrenten
| Bedrijf | P/B-ratio | Verschil in P/B-ratio | Land |
|---|---|---|---|
| 4.7411 | 38.77% |
US
|
|
| 3.0143 | -11.77% |
US
|
|
| 31.051 | 808.88% |
US
|
|
| - | - |
CN
|
|
| 6.6641 | 95.06% |
US
|
